HK Stock MarketDetailed Quotes

08247 BIOSINO BIO-TEC

Watchlist
  • 0.650
  • +0.090+16.07%
Market Closed Mar 28 16:08 CST
94.06MMarket Cap-7303P/E (TTM)

BIOSINO BIO-TEC Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
(Q9)Sep 30, 2021
Turnover
-22.52%289.07M
-23.61%210.56M
-19.31%139.15M
-19.71%71.1M
7.14%373.07M
5.32%275.66M
-1.28%172.44M
9.48%88.56M
7.06%348.23M
16.04%261.74M
Operating income
-22.52%289.07M
-23.61%210.56M
-19.31%139.15M
-19.71%71.1M
7.14%373.07M
5.32%275.66M
-1.28%172.44M
9.48%88.56M
7.06%348.23M
16.04%261.74M
Cost of sales
28.70%-161.71M
32.02%-108.67M
29.22%-72.47M
27.31%-39.16M
-10.83%-226.79M
-13.82%-159.85M
-9.35%-102.38M
-18.17%-53.87M
4.69%-204.63M
0.23%-140.44M
Operating expenses
28.70%-161.71M
32.02%-108.67M
29.22%-72.47M
27.31%-39.16M
-10.83%-226.79M
-13.82%-159.85M
-9.35%-102.38M
-18.17%-53.87M
4.69%-204.63M
0.23%-140.44M
Gross profit
-12.93%127.37M
-12.02%101.89M
-4.82%66.68M
-7.91%31.94M
1.87%146.28M
-4.52%115.81M
-13.55%70.06M
-1.74%34.69M
29.88%143.59M
43.06%121.3M
Selling expenses
-7.22%-58.95M
-12.01%-49.5M
-7.90%-30.71M
1.94%-14.49M
-2.15%-54.98M
11.10%-44.19M
19.74%-28.46M
8.55%-14.78M
10.32%-53.82M
4.48%-49.71M
Administrative expenses
-15.12%-51.45M
-17.58%-38.34M
-20.63%-25.8M
-24.73%-11.92M
-13.29%-44.69M
-4.56%-32.6M
-0.78%-21.38M
-3.17%-9.56M
-15.63%-39.45M
-5.88%-31.18M
Research and development expenses
-33.27%-35.81M
-37.58%-25.68M
-32.75%-15.95M
-72.53%-8.75M
-7.71%-26.87M
-4.40%-18.66M
3.89%-12.02M
12.52%-5.07M
11.63%-24.94M
11.92%-17.88M
Impairment and provision
-267.01%-712K
----
----
----
-50.39%-194K
----
----
----
-102.38%-129K
----
-Other impairment is provision
-267.01%-712K
----
----
----
-50.39%-194K
----
----
----
-102.38%-129K
----
Operating interest expense
----
----
----
----
----
----
----
----
---10.57M
----
Special items of operating profit
-437.72%-4.01M
-110.13%-128K
-69.49%292K
-42.98%65K
92.43%-745K
198.83%1.26M
16,050.00%957K
500.00%114K
-155.56%-9.85M
-111.60%-1.28M
Operating profit
-225.33%-23.56M
-154.32%-11.75M
-160.01%-5.49M
-158.54%-3.16M
288.89%18.8M
1.73%21.62M
-22.75%9.15M
31.54%5.39M
-57.39%4.83M
456.24%21.25M
Financing cost
6.15%-6.4M
5.01%-4.8M
7.92%-2.95M
-11.40%-1.44M
---6.82M
31.89%-5.05M
41.73%-3.21M
29.97%-1.29M
----
7.54%-7.42M
Share of profits of associates
88.59%12.41M
151.31%8.47M
113.21%2.66M
38.87%-541K
466.27%6.58M
2,692.31%3.37M
427.00%1.25M
-13.17%-885K
-47.49%1.16M
-106.96%-130K
Share of profit from joint venture company
-36.96%-63K
-50.00%-42K
-61.11%-29K
-88.89%-17K
-111.19%-46K
17.65%-28K
37.93%-18K
---9K
595.18%411K
---34K
Earning before tax
-195.12%-17.61M
-140.76%-8.12M
-181.01%-5.81M
-260.55%-5.15M
189.00%18.52M
45.63%19.91M
9.56%7.17M
117.41%3.21M
197.31%6.41M
212.82%13.67M
Tax
62.26%-1.63M
-1.85%-2.58M
9.80%-2.2M
7.24%-1.01M
-32.86%-4.31M
-37.47%-2.54M
-76.94%-2.44M
-1.87%-1.09M
-13.49%-3.25M
-518.79%-1.84M
After-tax profit from continuing operations
-235.48%-19.24M
-161.56%-10.7M
-269.29%-8.01M
-391.03%-6.16M
349.43%14.2M
46.90%17.38M
-8.42%4.73M
422.96%2.12M
547.59%3.16M
195.26%11.83M
Earning after tax
-235.48%-19.24M
-161.56%-10.7M
-269.29%-8.01M
-391.03%-6.16M
349.43%14.2M
46.90%17.38M
-8.42%4.73M
422.96%2.12M
547.59%3.16M
195.26%11.83M
Minority profit
-224.56%-7.59M
-177.03%-4.71M
-162.30%-2.59M
-138.05%-1.03M
41.77%6.1M
52.78%6.11M
24.71%4.15M
156.58%2.71M
225.58%4.3M
253.53%4M
Profit attributable to shareholders
-243.70%-11.65M
-153.18%-5.99M
-1,038.24%-5.42M
-763.97%-5.13M
811.05%8.11M
43.90%11.27M
-68.52%578K
8.90%-594K
-141.94%-1.14M
179.80%7.83M
Basic earnings per share
-242.86%-0.08
-152.56%-0.041
-1,025.00%-0.037
-300.00%-0.04
800.00%0.056
56.00%0.078
-69.23%0.004
0.00%-0.01
-142.11%-0.008
171.43%0.05
Diluted earnings per share
-242.86%-0.08
-152.56%-0.041
-1,025.00%-0.037
-300.00%-0.04
800.00%0.056
56.00%0.078
-69.23%0.004
0.00%-0.01
-142.11%-0.008
171.43%0.05
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
Auditor
--
--
--
--
Ernst & Young
--
--
--
Ernst & Young
--
(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021(Q9)Sep 30, 2021
Turnover -22.52%289.07M-23.61%210.56M-19.31%139.15M-19.71%71.1M7.14%373.07M5.32%275.66M-1.28%172.44M9.48%88.56M7.06%348.23M16.04%261.74M
Operating income -22.52%289.07M-23.61%210.56M-19.31%139.15M-19.71%71.1M7.14%373.07M5.32%275.66M-1.28%172.44M9.48%88.56M7.06%348.23M16.04%261.74M
Cost of sales 28.70%-161.71M32.02%-108.67M29.22%-72.47M27.31%-39.16M-10.83%-226.79M-13.82%-159.85M-9.35%-102.38M-18.17%-53.87M4.69%-204.63M0.23%-140.44M
Operating expenses 28.70%-161.71M32.02%-108.67M29.22%-72.47M27.31%-39.16M-10.83%-226.79M-13.82%-159.85M-9.35%-102.38M-18.17%-53.87M4.69%-204.63M0.23%-140.44M
Gross profit -12.93%127.37M-12.02%101.89M-4.82%66.68M-7.91%31.94M1.87%146.28M-4.52%115.81M-13.55%70.06M-1.74%34.69M29.88%143.59M43.06%121.3M
Selling expenses -7.22%-58.95M-12.01%-49.5M-7.90%-30.71M1.94%-14.49M-2.15%-54.98M11.10%-44.19M19.74%-28.46M8.55%-14.78M10.32%-53.82M4.48%-49.71M
Administrative expenses -15.12%-51.45M-17.58%-38.34M-20.63%-25.8M-24.73%-11.92M-13.29%-44.69M-4.56%-32.6M-0.78%-21.38M-3.17%-9.56M-15.63%-39.45M-5.88%-31.18M
Research and development expenses -33.27%-35.81M-37.58%-25.68M-32.75%-15.95M-72.53%-8.75M-7.71%-26.87M-4.40%-18.66M3.89%-12.02M12.52%-5.07M11.63%-24.94M11.92%-17.88M
Impairment and provision -267.01%-712K-------------50.39%-194K-------------102.38%-129K----
-Other impairment is provision -267.01%-712K-------------50.39%-194K-------------102.38%-129K----
Operating interest expense -----------------------------------10.57M----
Special items of operating profit -437.72%-4.01M-110.13%-128K-69.49%292K-42.98%65K92.43%-745K198.83%1.26M16,050.00%957K500.00%114K-155.56%-9.85M-111.60%-1.28M
Operating profit -225.33%-23.56M-154.32%-11.75M-160.01%-5.49M-158.54%-3.16M288.89%18.8M1.73%21.62M-22.75%9.15M31.54%5.39M-57.39%4.83M456.24%21.25M
Financing cost 6.15%-6.4M5.01%-4.8M7.92%-2.95M-11.40%-1.44M---6.82M31.89%-5.05M41.73%-3.21M29.97%-1.29M----7.54%-7.42M
Share of profits of associates 88.59%12.41M151.31%8.47M113.21%2.66M38.87%-541K466.27%6.58M2,692.31%3.37M427.00%1.25M-13.17%-885K-47.49%1.16M-106.96%-130K
Share of profit from joint venture company -36.96%-63K-50.00%-42K-61.11%-29K-88.89%-17K-111.19%-46K17.65%-28K37.93%-18K---9K595.18%411K---34K
Earning before tax -195.12%-17.61M-140.76%-8.12M-181.01%-5.81M-260.55%-5.15M189.00%18.52M45.63%19.91M9.56%7.17M117.41%3.21M197.31%6.41M212.82%13.67M
Tax 62.26%-1.63M-1.85%-2.58M9.80%-2.2M7.24%-1.01M-32.86%-4.31M-37.47%-2.54M-76.94%-2.44M-1.87%-1.09M-13.49%-3.25M-518.79%-1.84M
After-tax profit from continuing operations -235.48%-19.24M-161.56%-10.7M-269.29%-8.01M-391.03%-6.16M349.43%14.2M46.90%17.38M-8.42%4.73M422.96%2.12M547.59%3.16M195.26%11.83M
Earning after tax -235.48%-19.24M-161.56%-10.7M-269.29%-8.01M-391.03%-6.16M349.43%14.2M46.90%17.38M-8.42%4.73M422.96%2.12M547.59%3.16M195.26%11.83M
Minority profit -224.56%-7.59M-177.03%-4.71M-162.30%-2.59M-138.05%-1.03M41.77%6.1M52.78%6.11M24.71%4.15M156.58%2.71M225.58%4.3M253.53%4M
Profit attributable to shareholders -243.70%-11.65M-153.18%-5.99M-1,038.24%-5.42M-763.97%-5.13M811.05%8.11M43.90%11.27M-68.52%578K8.90%-594K-141.94%-1.14M179.80%7.83M
Basic earnings per share -242.86%-0.08-152.56%-0.041-1,025.00%-0.037-300.00%-0.04800.00%0.05656.00%0.078-69.23%0.0040.00%-0.01-142.11%-0.008171.43%0.05
Diluted earnings per share -242.86%-0.08-152.56%-0.041-1,025.00%-0.037-300.00%-0.04800.00%0.05656.00%0.078-69.23%0.0040.00%-0.01-142.11%-0.008171.43%0.05
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --------Unqualified Opinion------Unqualified Opinion--
Auditor --------Ernst & Young------Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg